Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Critical Care Clinics|October 30, 2007
Cardiogenic shock complicating myocardial infarctionHitinder S Gurm, Eric R BatesThe American Journal of Cardiology|December 15, 2018
Pre-hospital Transport Times and Outcomes After Different Reperfusion Strategies for ST-Elevation Myocardial InfarctionHedvig B Andersson, Milan Seth, Hitinder S Gurm, et al.Circulation. Cardiovascular Interventions|February 7, 2015
Comparative effectiveness and safety of a catheterization laboratory-only eptifibatide dosing strategy in patients undergoing percutaneous coronary interventionHitinder S Gurm, Carrie Hosman, Eric R Bates, et al.Interventional Cardiology Clinics|September 6, 2023
A Practical Approach to Preventing Contrast-Associated Renal Complications in the Catheterization LaboratoryHitinder S GurmCirculation. Cardiovascular Interventions|December 25, 2009
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trialsHitinder S Gurm, Umesh Tamhane, Pascal Meier, et al.Current Cardiology Reports|February 9, 2012
Carotid Artery Stenting Versus Carotid Endarterectomy: Post CRESTMichael Buschur, Hitinder S GurmInterventional Cardiology Clinics|June 6, 2017
Predicting Contrast-induced Renal Complications in the Catheterization LaboratoryJudith Kooiman, Hitinder S GurmInterventional Cardiology Clinics|May 31, 2020
A Practical Approach to Preventing Renal Complications in the Catheterization LaboratoryDevika Aggarwal, Hitinder S GurmCleveland Clinic Journal of Medicine|December 3, 2003
The Heart Protection Study: high-risk patients benefit from statins, regardless of LDL-C levelHitinder S Gurm, Byron HoogwerfCurrent Opinion in Investigational Drugs (London, England : 2000)|August 24, 2010
M-118, a novel, low-molecular-weight heparin for the potential treatment of cardiovascular disordersHriday Shah, Hitinder S GurmPageof 32